There is a perception that setting veterinary antibiotic usage (AMU) reduction targets will result in a parallel reduction in the prevalence of antibiotic resistance while maintaining the current level of animal health and not resulting in animal welfare concerns. This presentation will address the consequences of setting AMU reduction targets in poultry production and maintain that the focus should be on the responsible use of antibiotics.
Content reserved for the people registered for the event.
Please enter the email used to register for this event to unlock the reserved content:
Dr Simjee graduated from the University of Birmingham Medical School in England in 1992, he specialised in infectious diseases completing a M. Sc. in 1994 and a Ph. D. in 1998 also from the University of Birmingham Medical School. After a brief time in research he went to work at the US FDA between 2000-2003 at the Centre for Veterinary Medicine specifically looking at gene transfer between animal and human pathogens. He returned back to the UK in 2004 to take up a position at Elanco Animal Health as global technical and regulatory advisor on antibiotics.
Dr Simjee is past-chair of the VetPath program a Pan European AMR monitoring program and past co-chair of the CLSI veterinary antimicrobial susceptibility testing sub-committee. He has served 9 years as editor for Journal of Antimicrobial Chemotherapy, 10 years as editor for Antimicrobial Agents and Chemotherapy and continues to serve as editor on International Journal of Antimicrobial Agents.
Dr Simjee is currently serving as chief Medical Officer at Elanco Animal Health with global responsibilities for Elanco’s antimicrobial portfolio.